BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 278 filers reported holding BLUEPRINT MEDICINES CORP in Q4 2020. The put-call ratio across all filers is 4.17 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,884,787 | +31.2% | 316,304 | +65.2% | 0.02% | +35.7% |
| Q2 2023 | $12,103,558 | +60.8% | 191,512 | +14.4% | 0.01% | +55.6% |
| Q1 2023 | $7,529,166 | +20.1% | 167,352 | +16.9% | 0.01% | +12.5% |
| Q4 2022 | $6,270,262 | -25.0% | 143,124 | +12.8% | 0.01% | -20.0% |
| Q3 2022 | $8,359,000 | +72.4% | 126,924 | +32.2% | 0.01% | +66.7% |
| Q2 2022 | $4,850,000 | -24.8% | 96,024 | -4.9% | 0.01% | 0.0% |
| Q1 2022 | $6,453,000 | -43.1% | 101,024 | -4.6% | 0.01% | -33.3% |
| Q4 2021 | $11,343,000 | +33.4% | 105,902 | +28.0% | 0.01% | 0.0% |
| Q3 2021 | $8,506,000 | +26.6% | 82,738 | +8.2% | 0.01% | +28.6% |
| Q2 2021 | $6,717,000 | -8.4% | 76,438 | +1.3% | 0.01% | -12.5% |
| Q1 2021 | $7,333,000 | -1.1% | 75,424 | +14.1% | 0.01% | -11.1% |
| Q4 2020 | $7,414,000 | +33.3% | 66,109 | +10.2% | 0.01% | +12.5% |
| Q3 2020 | $5,562,000 | +21.1% | 59,995 | +1.9% | 0.01% | +14.3% |
| Q2 2020 | $4,594,000 | +38.8% | 58,895 | +4.1% | 0.01% | +16.7% |
| Q1 2020 | $3,310,000 | -30.1% | 56,595 | -4.3% | 0.01% | -14.3% |
| Q4 2019 | $4,736,000 | -4.0% | 59,118 | -11.9% | 0.01% | -12.5% |
| Q3 2019 | $4,931,000 | -25.4% | 67,118 | -4.3% | 0.01% | -20.0% |
| Q2 2019 | $6,614,000 | +31.7% | 70,118 | +11.8% | 0.01% | +25.0% |
| Q1 2019 | $5,021,000 | +47.8% | 62,725 | -0.5% | 0.01% | +33.3% |
| Q4 2018 | $3,398,000 | -29.3% | 63,025 | +2.4% | 0.01% | -14.3% |
| Q3 2018 | $4,803,000 | +20.6% | 61,525 | -1.9% | 0.01% | +16.7% |
| Q2 2018 | $3,982,000 | -31.8% | 62,725 | -1.5% | 0.01% | -33.3% |
| Q1 2018 | $5,837,000 | +27.4% | 63,655 | +4.8% | 0.01% | +28.6% |
| Q4 2017 | $4,582,000 | +27.6% | 60,755 | +17.9% | 0.01% | +40.0% |
| Q3 2017 | $3,591,000 | +45.7% | 51,540 | +5.9% | 0.01% | +25.0% |
| Q2 2017 | $2,465,000 | +48.0% | 48,654 | +16.8% | 0.00% | +33.3% |
| Q1 2017 | $1,666,000 | +244.2% | 41,654 | +141.6% | 0.00% | +200.0% |
| Q4 2016 | $484,000 | +66.3% | 17,239 | +75.9% | 0.00% | 0.0% |
| Q3 2016 | $291,000 | +16.9% | 9,800 | -20.3% | 0.00% | – |
| Q2 2016 | $249,000 | +12.2% | 12,300 | 0.0% | 0.00% | – |
| Q1 2016 | $222,000 | -35.7% | 12,300 | -6.1% | 0.00% | -100.0% |
| Q4 2015 | $345,000 | +23.2% | 13,100 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $280,000 | -18.6% | 13,100 | +0.8% | 0.00% | 0.0% |
| Q2 2015 | $344,000 | – | 13,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 645,539 | $69,144,000 | 7.84% |
| DAFNA Capital Management LLC | 206,911 | $22,162,000 | 5.57% |
| Eagle Health Investments LP | 192,639 | $20,634,000 | 5.03% |
| Casdin Capital, LLC | 1,550,000 | $166,021,000 | 4.68% |
| CADIAN CAPITAL MANAGEMENT, LP | 450,657 | $48,270,000 | 2.65% |
| Avidity Partners Management LP | 995,000 | $106,574,000 | 2.26% |
| Integral Health Asset Management, LLC | 75,000 | $8,033,000 | 2.22% |
| Rock Springs Capital Management LP | 859,755 | $92,088,000 | 2.13% |
| Boxer Capital, LLC | 507,374 | $54,345,000 | 2.11% |
| EFG Asset Management (North America) Corp. | 112,715 | $12,082,000 | 1.58% |